Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Michael Walter

Michael Walter
Managing Editor


Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

LATEST ARTICLES BY THIS AUTHOR

FDA approves design updates for Perceval Plus surgical aortic valve
Cardiologists are first in world to use new TAVR catheter from Boston Scientific
FDA approves first new clot-dissolving drug for ischemic stroke in decades
TAVR vs. SAVR: Real-world data highlight advantages of both techniques
Cleerly and Bunkerhill Health unite in the name of AI-based cardiac imaging evaluations
Cardiologists treat first commercial patients with FDA-cleared valve-in-valve TAVR device
Shockwave Medical launches new IVL catheter for targeting challenging lesions in PAD patients
Philips pulls endovascular devices from market after safety issues prompt Class I recall
Boston Scientific enters renal denervation market with acquisition worth up to $540M
Cardiologists recommend complete revascularization, intravascular imaging in new ACS guidelines

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …100
    • Page 101
    • Page 102
    • Page 103
    • Current page 104
    • Page 105
    • Page 106
    • Page 107
    • Page 108 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme